TIE1, Fc Chimera, Recombinant, Human, His-Tag, aa22-760

Catalog No : USB-209242
1100.03€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name TIE1, Fc Chimera, Recombinant, Human, His-Tag, aa22-760
Catalog No USB-209242
Supplier’s Catalog No 209242
Supplier US Biologicals
Source antigen Recombinant, NSO cells
Reactivity
Cross reactivity
Applications
Molecular weight 130140
Storage -20°C
Other names
Grade Purified
Purity Purified (~90%)
Form Supplied as a liquid in PBS, pH 7.4, 0.1% albumin.
Reactivity life 12 months
Note For reserch purpose only
Purity Purified (~90%)
Description Embryonic vascular system undergoes a series of complex, highly regulated series of events involving differentiation, migration and association of primitive endothelial cells. This process is termed vasculogenesis. A further remodeling of the primitive vascular system forms the mature cardiovascular system. This process is known as angiogenesis (sprouting of new capillary vessels from pre-existing vasculature). A family of receptor tyrosine kinases TIE1 and TIE 2 or Tek has been identified in vascular endothelium and hematopoietic cells. Mice lacking TIE 1 or TIE 2 are lethal. Ties may represent the earliest endothelial cell lineage marker and may regulate the endothelial cell proliferation, differentiation, and proper patterning during vasculogenesis. TIEs appear to be acting downstream of the VEGFRs. Tie-1 (human 1138aa; mouse 1134aa) is a type 1 membrane receptor protein specifically expressed in developing vascular endothelial cells. Tie-1 extracellular portion (aa25-279) contains 3 fibronectin type III-like and 2 Ig-like C2-type, and 3-EGF-like domains. Source: Recombinant protein corresponding to the EC domain, aa22-760, of human Tie-1, His-tagged Fc protein chimera, expressed in NSO cells. Molecular Weight: ~130-140kD under reducing conditions. Endotoxin: <0.1ng/1ug Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.